NEW YORK CITY: US biotech company Medivation has opened the door to being bought by either Pfizer or Amgen, a person familiar with the matter told Agence France-Presse on Tuesday.
Less than two weeks after rebuffing a $9.3 billion bid from French giant Sanofi, the San Francisco developer of anti-cancer therapies has now signed non-disclosure agreements related to merger talks with the two US pharmaceutical companies, the source confirmed.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.